NOS3 and myeloid sarcoma: Although the direct connection between NO activity and lipid metabolism remains unclear, we hypothesize that the impact of −786T/C polymorphism in NOS3 gene on clinical features of MS including cholesterol metabolism might be less severe than the knockout of the whole gene.